Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments

A Angelousi; Kimberly Kamp; M Kaltsatou; D O'Toole; G Kaltsas; W.W. de Herder

doi:10.1159/000456035

Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments

A Angelousi, Kimberly Kamp, M Kaltsatou, D O'Toole, G Kaltsas, W.W. de Herder

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	394-402
Number of pages	9
Journal	Neuroendocrinology
Volume	105
Issue number	4
DOIs	https://doi.org/10.1159/000456035
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1159/000456035

http://hdl.handle.net/1765/108214

Cite this

@article{36f10e5a1f0e4dd8bcdb173db5b913f9,

title = "Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments",

author = "A Angelousi and Kimberly Kamp and M Kaltsatou and D O'Toole and G Kaltsas and {de Herder}, W.W.",

year = "2017",

doi = "10.1159/000456035",

language = "Undefined/Unknown",

volume = "105",

pages = "394--402",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "Karger",

number = "4",

}

TY - JOUR

T1 - Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments

AU - Angelousi, A

AU - Kamp, Kimberly

AU - Kaltsatou, M

AU - O'Toole, D

AU - Kaltsas, G

AU - de Herder, W.W.

PY - 2017

Y1 - 2017

U2 - 10.1159/000456035

DO - 10.1159/000456035

M3 - Article

SN - 0028-3835

VL - 105

SP - 394

EP - 402

JO - Neuroendocrinology

JF - Neuroendocrinology

IS - 4

ER -